Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-068453

General Counsel and Secretary gave up 6,303 shares (to pay taxes)

  • General Counsel and Secretary acquired 13,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2021-12-03 Option exercise +13,333 49,845 D: show line 1 in the form
KASINGER JAMES R. General Counsel and Secretary 2021-12-06 Shares withheld for taxes −6,303 $69.17 $435,979 43,542 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2021-12-03 Option exercise · Restricted Stock Units +13,333 6,667 D: show line 3 in the form
Loading xslF345X03/doc4.xml…